Award-winning actor 'regains feeling in feet' with new MND drug 50 minutes ago Share Save Aileen Moynagh BBC News NI health reporter Share Save BBC Michael Campbell was diagnosed with the terminal disease in February 2023 A Belfast actor who won high praise for playing Richard III in a wheelchair, is hoping a new clinical trial drug will help him in his fight against Motor Neurone Disease (MND). M...
Award-winning actor 'regains feeling in feet' with new MND drug 50 minutes ago Share Save Aileen Moynagh BBC News NI health reporter Share Save BBC Michael Campbell was diagnosed with the terminal disease in February 2023 A Belfast actor who won high praise for playing Richard III in a wheelchair, is hoping a new clinical trial drug will help him in his fight against Motor Neurone Disease (MND). Michael Campbell, also known as Michael Patrick, was diagnosed with the terminal disease in February 2023. MND is usually life-shortening and there is currently no cure, but treatment can help manage the symptoms. Since beginning the trial drug, the 35-year-old has regained some feeling in his feet, and is hoping for further benefits. "It was such a relief that the drug is doing something," he said. "I'm probably still going to die pretty soon, but maybe I'll get an extra year or two." It was while acting in a show at the Dublin Fringe Festival three years ago that Campbell, who has also appeared in award-winning police drama Blue Lights, started experiencing symptoms. "I had to dance in the play, and I kept falling over," he said. "I kept blaming the shoes being like, why have they me dancing in these clumpy shoes? "But afterwards it didn't get better." He said getting diagnosed with MND months later was "terrible". "It was grim, it was hard, but I got a lot of love and family and friends to help me through it," he said. Campbell's family had been fundraising to enable him to have private care. What is MND? Michael Campbell is pictured in his wheelchair with his wife Naomi MND is condition that affects the nerves found in the brain and spinal cord, which tell your muscles what to do. It causes weakness that gets worse over time and can significantly shorten life expectancy. International rugby players Rob Burrow and Doddie Weir raised awareness of the terminal neurological illness before they died, as did Irish journalist and broadcaster Charlie Bird. In less than a year af...
An oil tanker is docked at a pier at the El Palito refinery of the state oil company PDVSA. Jesus Vargas | Picture Alliance | Getty Images President Donald Trump said on Tuesday evening that the interim authorities in Venezuela will be turning over between 30 million to 50 million barrels of oil to the United States. Trump, who announced the transfer in a social media post , said the oil will be s...
An oil tanker is docked at a pier at the El Palito refinery of the state oil company PDVSA. Jesus Vargas | Picture Alliance | Getty Images President Donald Trump said on Tuesday evening that the interim authorities in Venezuela will be turning over between 30 million to 50 million barrels of oil to the United States. Trump, who announced the transfer in a social media post , said the oil will be sold at its market price, "and that money will be controlled by me, as President of the United States of America, to ensure it is used to benefit the people of Venezuela and the United States!" "I have asked Energy Secretary Chris Wright to execute this plan, immediately. It will be taken by storage ships, and brought directly to unloading docks in the United States," Trump wrote. This is breaking news. Please refresh for updates.
(RTTNews) - The Singapore stock market has moved higher in three straight sessions, advancing more than 55 points or 1.3 percent along the way. The Straits Times Index now rests just shy of the 4,020-point plateau and it's tipped to open in the green again on Friday. The global forecast for the Asian markets is positive thanks to better than expected U.S. employment data. The European and U.S. mar...
(RTTNews) - The Singapore stock market has moved higher in three straight sessions, advancing more than 55 points or 1.3 percent along the way. The Straits Times Index now rests just shy of the 4,020-point plateau and it's tipped to open in the green again on Friday. The global forecast for the Asian markets is positive thanks to better than expected U.S. employment data. The European and U.S. markets were up and the Asian bourses figure to follow that lead. The STI finished modestly higher on Thursday following gains from the financial shares, property stocks and industrial issues. For the day, the index added 8.80 points or 0.22 percent to finish at the daily high of 4,019.57 after trading as low as 4,001.84. Among the actives, CapitaLand Ascendas REIT added 0.73 percent, while CapitaLand Integrated Commercial Trust shed 0.45 percent, CapitaLand Investment improved 0.74 percent, City Developments soared 2.23 percent, Comfort DelGro rallied 1.40 percent, DBS Group collected 0.22 percent, DFI Retail Group surged 4.98 percent, Hongkong Land spiked 1.74 percent, Keppel DC REIT dropped 0.85 percent, Keppel Ltd accelerated 1.45 percent, Mapletree Pan Asia Commercial Trust advanced 0.79 percent, Mapletree Industrial Trust, Seatrium Limited and SembCorp Industries all strengthened 0.98 percent, Mapletree Logistics Trust climbed 0.85 percent, SATS lost 0.32 percent, Singapore Technologies Engineering gained 0.63 percent, SingTel sank 0.77 percent, United Overseas Bank was up 0.03 percent, UOL Group slumped 1.19 percent, Wilmar International jumped 1.03 percent, Yangzijiang Financial skyrocketed 6.96 percent and Yangzijiang Shipbuilding, Genting Singapore, Thai Beverage and Oversea-Chinese Banking Corporation were unchanged. The lead from Wall Street is upbeat as the major averages opened higher on Thursday and remained in the green throughout the shortened session ahead of the July 4 holiday. The Dow rallied 344.11 points or 0.77 percent to finish at 44,828.53, while the N...
British aerospace engine maker Rolls-Royce wants India to be more than just a buyer of its engines, proposing to treat the country as a “home market” by building, designing and developing aircraft engines locally rather than simply selling them from abroad. Analysts said such a shift could provide a significant lift to New Delhi’s effort to build a fifth-generation stealth fighter under the Advanc...
British aerospace engine maker Rolls-Royce wants India to be more than just a buyer of its engines, proposing to treat the country as a “home market” by building, designing and developing aircraft engines locally rather than simply selling them from abroad. Analysts said such a shift could provide a significant lift to New Delhi’s effort to build a fifth-generation stealth fighter under the Advanced Medium Combat Aircraft (AMCA) programme, while forcing rival engine makers to offer deeper technology transfers to stay competitive. In an interview with the Press Trust of India late last month, Sashi Mukandan, executive vice-president of Rolls-Royce India, said developing a next-generation engine in the country was a priority to power future Indian combat jets, including the AMCA. Advertisement “If India is thinking about next-generation engines, Rolls-Royce is probably the best partner,” Mukandan said. “We have the capability, the experience both in India and globally, and we have repeatedly demonstrated that we can do it.” Mukandan said the AMCA engine core could be adapted for use as a naval marine engine and even for electric propulsion, noting that Rolls-Royce was among the few engine makers globally with the capability to convert an aircraft engine for marine use. Advertisement
Shanghai has announced a slew of new investments in hi-tech industries ranging from chips to artificial intelligence (AI) and aviation, becoming the latest Chinese city to unveil ambitious plans to boost local innovation amid an intensifying US-China tech race. The city’s Pudong district unveiled 50 big-ticket projects worth more than 70 billion yuan (US$10 billion) combined on Monday, with most o...
Shanghai has announced a slew of new investments in hi-tech industries ranging from chips to artificial intelligence (AI) and aviation, becoming the latest Chinese city to unveil ambitious plans to boost local innovation amid an intensifying US-China tech race. The city’s Pudong district unveiled 50 big-ticket projects worth more than 70 billion yuan (US$10 billion) combined on Monday, with most of the investment earmarked to flow into key industries including microchips, AI, biopharmaceuticals, smart vehicles and aviation, among others, local media reported. The exact funding sources for the projects have not been specified. Advertisement Shanghai is just the latest Chinese city to launch a tech investment spree going into the new year, as local officials across the country heed Beijing’s call to double down on developing self-sufficiency in core technologies as they map out their priorities for 2026 and beyond. Pudong, for instance, has set the goal of developing a chip industry with an annual economic output surpassing 500 billion yuan by 2030, as well as AI and aircraft manufacturing industries with outputs of over 200 billion yuan and 100 billion yuan, respectively. Advertisement Chen Jining , Shanghai’s party chief, said during an inspection tour on Sunday that local AI start-ups would receive the government’s full backing and that the city would tailor its policies to address their needs, according to official Shanghai media outlet Jiefang Daily. Shanghai will play an important role in China’s plans as the world’s second-largest economy confronts a high-stakes tech race with the United States, according to Fu Weigang, president of the Shanghai Institute of Finance and Law think tank.
00:06 Speaker A Time now for to watch Wednesday, January 7th. It's going to start off here on the labor front. We're going to be getting fresh job data on Wednesday with the ADP reading on private payrolls. That's expected to show growth in December with 50,000 jobs added, signaling a rebound in hiring momentum following the longest government shutdown in US history. 00:27 Speaker A Following the ...
00:06 Speaker A Time now for to watch Wednesday, January 7th. It's going to start off here on the labor front. We're going to be getting fresh job data on Wednesday with the ADP reading on private payrolls. That's expected to show growth in December with 50,000 jobs added, signaling a rebound in hiring momentum following the longest government shutdown in US history. 00:27 Speaker A Following the ADP report, we'll also be getting the job openings and labor turnover survey on Wednesday. Economist forecasting job openings to dip slightly compared to the previous month to 7.6 million, signaling that the labor market is cooling, but still above pre-pandemic norms. 00:46 Speaker A And we've got some earnings on deck as well. We're going to be tracking them. We're we're hearing from several names in the food and beverage sector, including Albertsons, Cal-Maine, and Constellation Brands. Constellation announced the results for you third quarter on Wednesday. Analysts expecting earnings to fall sharply in Q3, driven by the alcohol and beverage company selling off big chunks of its wine and spirits business. 01:09 Speaker A And finally, CES, formerly known as the Consumer Electronic Show continues in Las Vegas. Invidia CEO Jensen Wong giving a presentation on AI on Monday, covering everything from new chips to robots. Yahoo Finance will be interviewing the CFO of Qualcomm at CES on Wednesday. You don't want to miss that one.
Altria has an attractive 7.4% dividend yield backed by a growing dividend, but there is more for investors to consider. Altria (MO 2.02%) sells Marlboro cigarettes in the United States. It is one of the best-known brands in the world, at least among smokers. Add in Altria's steadily growing dividend and a 7.4% yield, and it would seem like this is a slam-dunk dividend stock for those looking to bu...
Altria has an attractive 7.4% dividend yield backed by a growing dividend, but there is more for investors to consider. Altria (MO 2.02%) sells Marlboro cigarettes in the United States. It is one of the best-known brands in the world, at least among smokers. Add in Altria's steadily growing dividend and a 7.4% yield, and it would seem like this is a slam-dunk dividend stock for those looking to build a million-dollar portfolio. That's doubly true if you compound those dividends by reinvesting them. There are just a couple of problems with Altria's story. Here's what you need to know before you buy this high-yield stock, thinking that it will help turn you into a millionaire. Altria's core is weak Altria is classified as a consumer staples company. That is because it sells a relatively low-cost product that consumers purchase on a regular basis, regardless of economic or stock market fluctuations. There's a nuance here, however, because Altria doesn't sell life necessities like food and toiletries; it sells tobacco products. Tobacco products are bought regularly because nicotine is addictive. This is where the problems start for Altria, because cigarettes are the primary way it provides nicotine to consumers. Smokable tobacco products account for nearly 90% of the company's revenues. Cigarettes account for just over 97% of its smokable tobacco product volumes. Sure, it owns the most important cigarette brand in the U.S. market, with a 40% overall market share and a nearly 60% share of the premium market. But that positive has to be juxtaposed against the fact that Altria's business is centered around one product and, really, just one brand, since Marlboro accounts for roughly 88% of the company's cigarette sales. Advertisement Being what amounts to a one-trick pony isn't actually the bad news. Many companies excel in one area, resulting in vibrant and growing businesses. Altria's problem is that it is a one-trick pony with a business that is steadily shrinking. The c...